Objectives: To study the association of genetic polymorphisms of coagulation factors with clinical and laboratory indicators in pregnant women with placental insufficiency with fetal growth retardation. Materials and methods: The study group included 250 pregnant women with placental insufficiency with fetal growth retardation (FGR). The control group consisted of 247 women without FGR. The participants were genotyped for four genetic markers of hereditary thrombophilia: fibrinogen (-455G/A FI), prothrombin (20210G/A FII), factor V Leiden (1691G/A FV), proconvertin (10976G/A FVII). Results: In the group of pregnant women with FGR, having genotypes -455GA FI and -455AA FI, a higher level of fibrinogen (4.7 g/l) is observed compared to women with the genotype -455GG FI (4.5 g/l, p=0.04). Conclusion: Thus, the study conducted on the relationship of polymorphic locus -455G/A FI with a higher level of fibrinogen in pregnant women with fetal growth retardation.
Introduction
Placental insufficiency is a syndrome caused by morphofunctional changes in the placenta, the progression of which develops a fetal growth retardation syndrome, often combined with hypoxia (Bamfo, Odibo, 2011 , Zollner et al., 2011 Unanyan et al., 2015) . Placental insufficiency (PI) is one of the most common complications of pregnancy (Serov et al., 2011; Diner et al., 2016) . Perinatal mortality in women who underwent placental insufficiency is among the full-term newborns 10.3 %, among preterm infants -49 % (Serov et al., 2011; Diner et al., 2016) . In 60% of cases, placental insufficiency leads to the development of FGR, which ranks third in the structure of the causes of perinatal morbidity (Serov et al., 2011) . Placental insufficiency has a multifactorial nature ( 
Materials and Methods

Object of Study
In total 497 unrelated pregnant women in the third trimester of pregnancy were recruited for the study during 2009-2013. All participants signed an informed consent before entering the study. The clinical and laboratory examination of the participants was conducted in the perinatal center of the Saint Joasaph Belgorod Regional Clinical Hospital. The following inclusion criteria were used to check eligibility of the participants: singleton pregnancy, Russian ethnicity. Patients having congenital malformations of internal genitals, uterine fibroids, anomalies of placental location, isosensitization of Rh factor or ABO, genetic diseases, were excluded from the study. 250 participants were diagnosed with the syndrome of fetal growth retardation of varying severity. The diagnosis of the syndrome was based on clinical data, ultrasound fetometry (TOSHIBA XARIO SSA-660A) and parameters of growth and weight after the birth. Based on the differences between the fetometric data and nomograms, three degrees of FGR were classified: 1 st degree corresponded to the reduction of the estimated gestational ages from the standard ones by 2 weeks, 2 nd degree -by 3-4 weeks, and 3 rd degree -by more than 4 weeks. The controls were 247 females without the syndrome of intrauterine growth retardation. The laboratory study included a clinical blood test (with determination of the number of basic blood elements, hematocrit indicator); biochemical blood test (total protein, total bilirubin, urea, creatinine, level of hepatic aminotransferases, alkaline phosphatase, glucose); coagulogram (prothrombin index, activated partial thromboplastin time, thrombin time (TB), fibrinogen, international normalized ratio (INR), ethanol test, b-naphtholol test), extended study of Copyright © 2018 Helix ISSN 2319 -5592 (Online) hemostatic system (detection of soluble fibrin monomer complexes), antithrombin-III, protein C and protein S, platelet aggregation tests); determination of blood type and Rh factor. Also, analyzes were performed to exclude the antiphospholipid syndrome (lupus anticoagulant, cardiolipin antibodies, antiphospholipid antibodies) and associated hereditary thrombophilia.
Molecular and Genetic methods
The participants were genotyped for four genetic markers of hereditary thrombophilia:
The material for the study was venous blood, obtained in a volume of 8-9 ml from the ulnar vein of pregnant women. All polymorphic variants of hereditary thrombophilia were analyzed using the method of polymerase chain reaction (PCR) of DNA synthesis in real-time (real-time-PCR).
Statistical Methods
The obtained genotypes were checked for their correspondence to the Hardy-Weinberg distribution (HWE) using the  2 -test. Association of the polymorphisms with FGR was estimated by analyzing 2×2 contingency tables with the χ 2 -test and the Yates' correction for continuity. The risk was estimated using odds ratio with 95% confidence intervals (95% CI). The median (Me) and interquartile range (Q25-Q75) were used to describe the traits studied, and the MannWhitney test for comparative analysis. The analyses were performed using STATISTICA 6.0 (StatSoft, USA). The Bonferroni correction was applied to adjust for multiple comparisons.
Results
Characteristics of pregnant women with FGR and control group are shown in Table 1 . The analysis of clinical and laboratory parameters in pregnant women with FGR and control group was carried out: a general blood test, a biochemical blood test, a coagulogram, as well as the level of antithrombin III and soluble fibrin-monomer complexes (SFMC), a general urine test. The associations of genetic variants of coagulation factors with clinico-laboratory indicators in pregnant women with FGR and in the control group were studied. 
